CHAMPION PHOENIX Trial
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Anti-clotting agent helps reduce the risk of intraprocedural events during percutaneous coronary intervention.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Anti-clotting agent helps reduce the risk of intraprocedural events during percutaneous coronary intervention.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. In a clinical trial, a self-expanding transcatheter aortic valve met the key… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with… read more.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Length of infection increases risk for atherosclerosis. HIV infection, not antiretroviral therapy… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Clinical trial finds that a strategy of using of a bare metal stent in the… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI,… read more.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Results of the EUROMAX trial presented at TCT 2013; findings simultaneously published… read more.
by Bruce Sylvester – Combined use of three DMARDs (disease-modifying antirheumatic drugs) for recent-onset rheumatoid arthritis (RA) is more effective than methotrexate monotherapy, researchers reported at the American… read more.
Children with juvenile idiopathic arthritis (JIA) undergoing early and aggressive combination drug therapy achieve clinical inactive disease more quickly than with less aggressive therapy, researchers reported at the… read more.
Treatment of psoriatic arthritis with early, aggressive pharmacologic intervention with disease-modifying antirheumatic drugs (DMARDs) while utilizing a a treat-to-target approach achieves better outcomes than standard care, researchers reported… read more.
by Bruce Sylvester – Anti-TNF treatment reduces risk of acute coronary syndrome, like heart attacks and angina, in rheumatoid arthritis patients, researchers reported at the American College of… read more.
by Bruce Sylvester – taken from the BMJ – British Medical Journal – Patients prescribed the smoking cessation drugs varenicline and buproprian are not at an increased risk… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.